Sanofi has agreed with the Department of Health (DoH) for the Philippines to reimburse $27.86 million worth of vaccines, though its press release associated with the decision suggests it may have been made through gritted teeth.
Despite agreeing to refund the costs of the leftover vaccines, Sanofi refused to acknowledge that this decision was in any way related to safety or quality issues with the Dengvaxia.
